Improving the assessment of overweight and obesity in people living with HIV and/or chronic hepatitis B

Improving the assessment of overweight and oBEsity in people living with HIV and/or chronic hepatitis B

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ISRCTN

Registry ID

ISRCTN13394880

Enrollment

100

Registered

2025-11-03

Start date

2025-09-27

Completion date

Unknown

Last updated

2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

People living with Human Immunodeficiency Virus (HIV) and/or chronic Hepatitis B Virus (HBV) Infections and Infestations

Interventions

This cross-sectional study will recruit 100 people living with HIV and/or chronic HBV from the Mortimer Market Centre in London. Participants will undergo body composition assessments using BIA, 3D sc

Eligibility

Sex/Gender

All

Age

18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Age =18 years 2. HIV-1 positive with viral load 30 seconds

Exclusion criteria

Exclusion criteria: 1. Wheelchair users 2. People with artificial electrical implants, such as pacemakers or defibrillators 3. People who have had bariatric surgery or are currently taking/recently completed a course (within <6 months) of GLP-1 receptor agonist therapies 4. Person living with HIV and/or chronic HBV and active Hepatitis C co-infection or who has completed HCV treatment within the previous 6 months

Design outcomes

Primary

Measure	Time frame
Acceptability of three body composition assessment tools measured using a validated questionnaire (based on the Theoretical Framework of Acceptability) immediately after each assessment. Completion rates and time taken to complete each assessment will also be recorded.	—

Secondary

Measure	Time frame
1. Body composition and cardiometabolic risk profiling using data from BIA, 3D scans, and standard anthropometric measures (e.g. BMI, waist circumference). We will also assess cardiometabolic risk using blood tests (lipids, HbA1c), blood pressure, QRISK3 score, liver fat (CAP score), and sarcopenia risk (Short Physical Performance Battery and grip strength) 2. Comparison of self- and clinician-perceived body shape with 3D scan data using the Stunkard Figure Rating Scale with the quantitative data from the 3D body scan (e.g. fat percentage, body proportions) 3. Participant experiences and perceptions. Qualitative interviews with a subset of participants will explore feelings about body image, weight monitoring, and preferences for body composition assessment tools	—

Measure

Time frame

1. Body composition and cardiometabolic risk profiling using data from BIA, 3D scans, and standard anthropometric measures (e.g. BMI, waist circumference). We will also assess cardiometabolic risk using blood tests (lipids, HbA1c), blood pressure, QRISK3 score, liver fat (CAP score), and sarcopenia risk (Short Physical Performance Battery and grip strength) 2. Comparison of self- and clinician-perceived body shape with 3D scan data using the Stunkard Figure Rating Scale with the quantitative data from the 3D body scan (e.g. fat percentage, body proportions) 3. Participant experiences and perceptions. Qualitative interviews with a subset of participants will explore feelings about body image, weight monitoring, and preferences for body composition assessment tools

—

Countries

England, United Kingdom

Contacts

Public ContactFlorence Bascombe

f.bascombe@ucl.ac.uk+44 7554411752

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026